- Lung Cancer Basics
Update on DOD Funding for Lung Cancer Research
WASHINGTON, DC [June 22, 2011]--Lung Cancer Alliance has been engaged in a protracted battle to save the Department of Defense's medical research program, including the lung cancer research program, from being eliminated by budget cutters. In meetings and letters to key Members of Congress, LCA strongly defended the program which to date has brought $47.8 million to lung cancer research projects around the country. The House Appropriations Committee last week approved an additional $10.2 million for lung cancer research. A floor vote by the full House of Representatives may occur this week. An amendment on the floor to strip the entire medical research program under DOD may be offered.
LCA said that the Appropriations Committee report expressed specific concern about " the high rate of lung cancer among military personnel and veterans. Lung cancer continues to be the most lethal of all caners, taking more lives annually than the next four most prevalent cancers combined. The five year survival rate is only fifteen percent. A major contributor to the low survival rate is that more than seventy percent of lung cancer diagnoses occur at a late stage."
For more information, click here.